Fresenius SE & Co KGaA at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Good afternoon, good morning, ladies and gentlemen, and thank you for joining us for another session of our 41st Goldman Sachs Global Healthcare Conference webcast. My name is Veronika Dubajova, and I'm the medtech analyst at Goldman Sachs in London. And it is with great pleasure that I am joined today by the management team of Fresenius SE, Stephan Sturm, CEO; and Markus Georgi, Head of IR. Thank you guys for being here and greetings to Bad Homburg.
We are going to conduct the session entirely as Q&A. (Operator Instructions)
So Stephan and Markus, thank you for being here.
Questions & Answers
I want to start with the topic du jour, which is Helios and COVID. And this has obviously been a big discussion point for everyone. But can you maybe give us an update on where you are in terms of volume and utilization levels, both in Spain and in Germany? And how has the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
